TWD 19.15
(1.06%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 1.75 Million TWD | -69.31% |
2022 | 5.73 Million TWD | 9.87% |
2021 | 5.21 Million TWD | -35.45% |
2020 | 8.08 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | - TWD | 0.0% |
2024 Q1 | - TWD | -100.0% |
2023 Q3 | 1.75 Million TWD | -53.12% |
2023 FY | 1.75 Million TWD | -69.31% |
2023 Q2 | 3.75 Million TWD | 0.0% |
2023 Q1 | 3.75 Million TWD | -34.54% |
2023 Q4 | 1.75 Million TWD | 0.0% |
2022 FY | 5.73 Million TWD | 9.87% |
2022 Q4 | 5.73 Million TWD | 0.0% |
2022 Q3 | 5.73 Million TWD | 0.0% |
2021 FY | 5.21 Million TWD | -35.45% |
2020 FY | 8.08 Million TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 60.65 Million TWD | 97.1% |
Level Biotechnology Inc. | 9.88 Million TWD | 82.205% |
Sagittarius Life Science Corp | 6.25 Million TWD | 71.874% |
NeoCore Technology Co., Ltd. | 33.65 Million TWD | 94.773% |
TaiMed Biologics Inc. | 521.7 Million TWD | 99.663% |
GlycoNex Incorporation | - TWD | -Infinity% |
VBI | - TWD | -Infinity% |
GeneReach Biotechnology Corp. | 97.74 Million TWD | 98.2% |
Taiwan Advance Bio-Pharmaceutical Inc. | 86.89 Million TWD | 97.976% |
Visgeneer Inc. | 114.17 Million TWD | 98.459% |
Mycenax Biotech Inc. | 569.78 Million TWD | 99.691% |
Sunmax Biotechnology Co., Ltd. | 144.77 Million TWD | 98.785% |
G&E Herbal Biotechnology Co., Ltd. | 1.29 Million TWD | -35.935% |
Medigen Vaccine Biologics Corporation | 254.35 Million TWD | 99.308% |
TaiwanJ Pharmaceuticals Co., Ltd. | 472 Thousand TWD | -272.669% |
TaiRx, Inc. | 8.96 Million TWD | 80.388% |
CHO Pharma, Inc. | - TWD | -Infinity% |
EirGenix Inc. | 436.54 Million TWD | 99.597% |
BioLASCO Taiwan Co., Ltd. | 51.43 Million TWD | 96.58% |
Sunny Pharmtech Inc. | 376.29 Million TWD | 99.533% |
Lin BioScience, Inc. | 29.02 Million TWD | 93.94% |
BioGend Therapeutics Co., Ltd. | 9.44 Million TWD | 81.368% |
Feng Chi Biotech Corp. | 8.14 Million TWD | 78.415% |
Bio Preventive Medicine Corp. | 106.2 Million TWD | 98.344% |
Lukas Biomedical Inc. | 69.9 Million TWD | 97.484% |
RBC Bioscience Corporation | 412.59 Million TWD | 99.574% |
BiOptic Inc. | 85.79 Million TWD | 97.95% |
BRIM Biotechnology, Inc. | 108 Thousand TWD | -1528.704% |
Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
Great Novel Therapeutics Biotech & Medicals | 10.88 Million TWD | 83.834% |
Syngen Biotech Co.,Ltd. | 386.07 Million TWD | 99.544% |
Anti-Microbial Savior BioteQ Co., Ltd | - TWD | -Infinity% |
SynCore Biotechnology Co.,Ltd | - TWD | -Infinity% |
Genomics BioSci & Tech. Co.,Ltd. | 222.24 Million TWD | 99.209% |
Neith Corporation | 714 Thousand TWD | -146.359% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
NaviFUS Corp. | 25.83 Million TWD | 93.192% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 366 Million TWD | 99.519% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 22.02 Million TWD | 92.013% |
Greenyn Biotechnology Co., Ltd | 55.91 Million TWD | 96.854% |
Lumosa Therapeutics Co., Ltd. | 8.11 Million TWD | 78.329% |
AP Biosciences Inc | 70.42 Million TWD | 97.502% |
Medigen Biotechnology Corp. | 449.09 Million TWD | 99.608% |
3D Global Biotech Inc. | 4.08 Million TWD | 56.908% |
Pharmosa Biopharm Inc. | 118.41 Million TWD | 98.515% |
Intech Biopharm Corporation | 970.4 Million TWD | 99.819% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 99.558% |
Eusol Biotech Co.,Ltd. | 1.6 Million TWD | -9.527% |
TWi Biotechnology, Inc. | 5.6 Million TWD | 68.606% |
Ever Supreme Bio Technology Co., Ltd | 503 Thousand TWD | -249.702% |
TCI GENE Inc. | - TWD | -Infinity% |
MegaPro Biomedical Co., Ltd | 5.62 Million TWD | 68.746% |
Senhwa Biosciences, Inc. | 3.28 Million TWD | 46.486% |
Taiwan Bio Therapeutics Co., Ltd | 250.51 Million TWD | 99.298% |
NatureWise Biotech & Medicals Corporation | 3.26 Million TWD | 46.126% |
PharmaEngine, Inc. | 7.14 Million TWD | 75.374% |
Savior Lifetec Corporation | 257.03 Million TWD | 99.316% |
TaiGen Biopharmaceuticals Holdings Limited | 58.71 Million TWD | 97.004% |
OBI Pharma, Inc. | 439.88 Million TWD | 99.6% |
Meribank Biotech Co., Ltd | 14.81 Million TWD | 88.124% |
Acepodia, Inc. | 233.45 Million TWD | 99.247% |
Caliway Biopharmaceuticals Co., Ltd. | 11.87 Million TWD | 85.186% |